Logo image of UCU.CA

UCORE RARE METALS INC (UCU.CA) Stock Fundamental Analysis

Canada - TSX-V:UCU - CA90348V3011 - Common Stock

8.5 CAD
+0.06 (+0.71%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, UCU scores 1 out of 10 in our fundamental rating. UCU was compared to 805 industry peers in the Metals & Mining industry. The financial health of UCU is average, but there are quite some concerns on its profitability. UCU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

UCU had negative earnings in the past year.
In the past year UCU has reported a negative cash flow from operations.
UCU had negative earnings in each of the past 5 years.
In the past 5 years UCU always reported negative operating cash flow.
UCU.CA Yearly Net Income VS EBIT VS OCF VS FCFUCU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of UCU (-17.48%) is comparable to the rest of the industry.
UCU has a Return On Equity of -23.85%. This is comparable to the rest of the industry: UCU outperforms 52.80% of its industry peers.
Industry RankSector Rank
ROA -17.48%
ROE -23.85%
ROIC N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
UCU.CA Yearly ROA, ROE, ROICUCU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for UCU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UCU.CA Yearly Profit, Operating, Gross MarginsUCU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, UCU has more shares outstanding
Compared to 5 years ago, UCU has more shares outstanding
The debt/assets ratio for UCU is higher compared to a year ago.
UCU.CA Yearly Shares OutstandingUCU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
UCU.CA Yearly Total Debt VS Total AssetsUCU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

UCU has an Altman-Z score of 24.07. This indicates that UCU is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of UCU (24.07) is better than 75.90% of its industry peers.
UCU has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of UCU (0.22) is worse than 68.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 24.07
ROIC/WACCN/A
WACCN/A
UCU.CA Yearly LT Debt VS Equity VS FCFUCU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 2.11 indicates that UCU has no problem at all paying its short term obligations.
With a Current ratio value of 2.11, UCU perfoms like the industry average, outperforming 53.29% of the companies in the same industry.
UCU has a Quick Ratio of 2.11. This indicates that UCU is financially healthy and has no problem in meeting its short term obligations.
UCU's Quick ratio of 2.11 is in line compared to the rest of the industry. UCU outperforms 55.40% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
UCU.CA Yearly Current Assets VS Current LiabilitesUCU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.31% over the past year.
EPS 1Y (TTM)22.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

UCU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UCU.CA Price Earnings VS Forward Price EarningsUCU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UCU.CA Per share dataUCU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UCU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UCORE RARE METALS INC

TSX-V:UCU (10/20/2025, 7:00:00 PM)

8.5

+0.06 (+0.71%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-01 2025-09-01
Earnings (Next)11-17 2025-11-17
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap823.57M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 15.9
P/tB 18.5
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS0.53
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.48%
ROE -23.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.04%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 24.07
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1731.92%
Cap/Depr(5y)1254.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-18.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-167.11%
OCF growth 3YN/A
OCF growth 5YN/A